Quest Diagnostics Reports Second Quarter 2022 Financial Results; Raises Guidance for Full Year 2022

Go back to Quest Diagnostics Reports Second Quarter 2022 Financial Results; Raises Guidance for Full Year 2022
Quest Diagnostics (NYSE: DGX) Delayed: 247.45 +0.37 (0.15%)
Previous Close $247.08    52 Week High $86.85 
Open $248.28    52 Week Low $59.66 
Day High $248.70    P/E 46.60 
Day Low $246.26    EPS $5.31 
Volume 989,498